278 results on '"Cotter, Finbarr E."'
Search Results
2. Bcl-2 Antisense Oligonucleotides Therapy for Cancer : Targeting the Mitochondria
3. Designing a Clinical Antisense Study
4. Lymphomas
5. Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML
6. Childhood, adolescent and young adult non-Hodgkin lymphoma: state of the science
7. GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death
8. Direct sequence analysis of 14q+ and 18q− chromosome junctions at the MBR and MCR revealing clustering within the MBR in follicular lymphoma
9. ‘Indolent’ mature B-cell lymphomas
10. Cutaneous cryptococcosis in Hodgkin lymphoma
11. New alternative phosphorylation sites on the cyclin dependent kinase 1/cyclin a complex in p53-deficient human cells treated with etoposide: possible association with etoposide-induced apoptosis
12. Altered gene expression patterns in intrauterine growth restriction: Potential role of hypoxia
13. Commentary for the historical review: a History of the British Journal of Haematology
14. Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia
15. A defining moment for hairy cell leukaemia
16. Emerging therapy for chronic lymphocytic leukaemia
17. The CLL Issue
18. The 13q and 11q B-cell chronic lymphocytic leukaemia-associated regions derive from a common ancestral region in the zebrafish
19. Trinucleotide repeat dynamic mutation identifying susceptibility in familial and sporadic chronic lymphocytic leukaemia
20. Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma
21. Targeting mitochondria to overcome conventional and bortezomib/proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cells
22. Microarray transcript profiling distinguishes the transient from the acute type of megakaryoblastic leukaemia (M7) in Downʼs syndrome, revealing PRAME as a specific discriminating marker
23. Designing a Clinical Antisense Study
24. Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22-23 deletion in classic mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research
25. Molecular basis of mantle cell lymphoma
26. Prognostic impact of immunoglobulin genes somatic hypermutation and chromosome 11q22-23 deletion in classical mantle cell lymphoma: A study from the Swiss Group for Clinical Cancer Research (SAKK)
27. Association of Mutations in the NALP3/CIAS1/PYPAF1 Gene With a Broad Phenotype Including Recurrent Fever, Cold Sensitivity, Sensorineural Deafness, and AA Amyloidosis
28. Mantle Cell Lymphoma: New Treatments Targeted to the Biology
29. Alloantigen-specific T-cell depletion in a major histocompatibility complex fully mismatched murine model provides effective graft-versus-host disease prophylaxis in the presence of lymphoid engraftment
30. Editorial
31. In vivo suppression of Bcl-XL expression facilitates chemotherapy-induced leukaemia cell death in a SCID/NOD-Hu model
32. Controlling the mitochondrial gatekeeper for effective chemotherapy
33. Genome "Chip" diagnostics for now and the future
34. Phase I Clinical and Pharmacokinetic Study of Bcl-2 Antisense Oligonucleotide Therapy in Patients With Non-Hodgkin’s Lymphoma
35. KINETIC MODELLING OF CHEMOTHERAPY INDUCED APOPTOSIS IN LYMPHOMA: MEDIAN RATE OF MITOCHONDRIAL PERMEABILITY TRANSITION AS AN INDEX OF CHEMOSENSITIVITY
36. REVERSING BCL-2 FUNCTION VIA THE MITOCHONDRIAL BENZODAZEPINE RECEPTOR: A NEW SMALL MOLECULE STRATEGY FOR IN VIVO CHEMOSENSITISATION
37. Antisense strategies for cancer.
38. A personal dedication to Sir David J Weatherall GBE, FRS (9 March 1933-8 December 2018)
39. Cytogenetic and molecular study of 32 Down syndrome families: potential leukaemia predisposing role of the most proximal segment of chromosome 21q
40. Molecular follow-up in gastric mucosa–associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial
41. PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanism
42. Transchromosomic cell model of Down syndrome shows aberrant migration, adhesion and proteome response to extracellular matrix
43. Detection of chromosome 11 alterations in blood and bone marrow by interphase cytogenetics in mantle cell lymphoma
44. Clonality in Langerhans' Cell Histiocytosis.
45. Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder. (Research letters)
46. Mycosis fungoides in childhood: an unusual presentation
47. Can exome scans be expected to be part of real-time decision-making in patients with haematological cancers?
48. RT-PCR Analysis of Breakpoints Involving the MLL Gene Located at 11q23 in Acute Leukemia
49. Bcl-2 Antisense Oligonucleotides Therapy for Cancer: Targeting the Mitochondria
50. Molecular Diagnostics of Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.